GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varex Imaging Corp (NAS:VREX) » Definitions » Return-on-Tangible-Equity

VREX (Varex Imaging) Return-on-Tangible-Equity : -0.51% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Varex Imaging Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Varex Imaging's annualized net income for the quarter that ended in Dec. 2024 was $-1.2 Mil. Varex Imaging's average shareholder tangible equity for the quarter that ended in Dec. 2024 was $233.4 Mil. Therefore, Varex Imaging's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was -0.51%.

The historical rank and industry rank for Varex Imaging's Return-on-Tangible-Equity or its related term are showing as below:

VREX' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -72.88   Med: 17.3   Max: 35.58
Current: -18.73

During the past 12 years, Varex Imaging's highest Return-on-Tangible-Equity was 35.58%. The lowest was -72.88%. And the median was 17.30%.

VREX's Return-on-Tangible-Equity is ranked worse than
66.53% of 759 companies
in the Medical Devices & Instruments industry
Industry Median: 2.64 vs VREX: -18.73

Varex Imaging Return-on-Tangible-Equity Historical Data

The historical data trend for Varex Imaging's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varex Imaging Return-on-Tangible-Equity Chart

Varex Imaging Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -72.88 15.03 17.04 20.42 -19.68

Varex Imaging Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 2.13 2.06 -79.38 -0.51

Competitive Comparison of Varex Imaging's Return-on-Tangible-Equity

For the Medical Devices subindustry, Varex Imaging's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varex Imaging's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Varex Imaging's Return-on-Tangible-Equity falls into.


;
;

Varex Imaging Return-on-Tangible-Equity Calculation

Varex Imaging's annualized Return-on-Tangible-Equity for the fiscal year that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Sep. 2024 )  (A: Sep. 2023 )(A: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Sep. 2024 )  (A: Sep. 2023 )(A: Sep. 2024 )
=-47.7/( (256.8+228 )/ 2 )
=-47.7/242.4
=-19.68 %

Varex Imaging's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=-1.2/( (228+238.8)/ 2 )
=-1.2/233.4
=-0.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Varex Imaging  (NAS:VREX) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Varex Imaging Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Varex Imaging's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Varex Imaging Business Description

Traded in Other Exchanges
N/A
Address
1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
Executives
Kimberley E. Honeysett officer: Vice President and Secretary 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Shubham Maheshwari officer: Chief Financial Officer C/O VEECO INSTRUMENTS INC., 1 TERMINAL DRIVE, PLAINVIEW NY 11803
Jay K. Kunkel director 21557 TELEGRAPH ROAD, SOUTHFIELD MI 48033
Ruediger Naumann-etienne director
Kathleen Bardwell director 9 BLACKBERRY DRIVE, HUDSON OH 44236
Sunny Sanyal director, officer: President and CEO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Kevin Bruce Yankton officer: Controller & CAO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Andrew Hartmann officer: SVP Sales & Marketing, Medical 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Timothy E Guertin director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Brian W Giambattista officer: SVP and GM, X-ray Detectors 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT 84104
Erich R Reinhardt director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Mark S. Jonaitis officer: SVP and GM, X-Ray Sources 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Clarence R Verhoef officer: SVP & Chief Financial Officer VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 95035
Rosebrough Walter M Jr director 5960 HEISLEY ROAD, MENTOR OH 44060
Carl E. Lacasce officer: SVP, Sales & Marketing 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104